Title:
疾患予防および治療における成長ホルモン受容体の遮断剤
Document Type and Number:
Japanese Patent JP6930916
Kind Code:
B2
Abstract:
Compounds and methods for treating diseases or conditions affected by the activity or expression of genes/proteins related to human GH, GHR, STAT5, SOCS, IGF-1, insulin are provided. Monoclonal antibodies for treating diseases or conditions related to growth hormone and growth hormone receptor activity are also provided.
Inventors:
Longo, Walter Dee.
Barras Bramanian, Preah
Neamathy, Nouri
Way, Min
Barras Bramanian, Preah
Neamathy, Nouri
Way, Min
Application Number:
JP2017541934A
Publication Date:
September 01, 2021
Filing Date:
February 12, 2016
Export Citation:
Assignee:
University of Southern California
International Classes:
A61K31/55; A61K31/341; A61P3/00; A61P3/10; A61P5/00; A61P5/08; A61P25/28; A61P35/00; A61P43/00
Domestic Patent References:
| JP2013500598A |
Foreign References:
| WO2006001770A1 | ||||
| WO2013192165A2 |
Other References:
DATABASE REGISTRY [ONLINE] Retrieved from STN,掲載日:2011年8月28日以前,検索日:2019年10月30日,CAS Registry No. 1324757-41-6, 1280496-33-4, 1203233-04-8, 1180307-90-7, 1180203-07-9, 1014381-09-9, 872319-25-0, 752215-38-6, 750624-95-4, 1169951-41-0, 1090351-93-1
Rosengren, L. et al.,In vivo evaluation of a novel, orally bioavailable, small molecule growth hormone receptor antagonist,Growth Hormone & IGF Research,2007年,17(1),pp. 47-53
Rosengren, L. et al.,In vivo evaluation of a novel, orally bioavailable, small molecule growth hormone receptor antagonist,Growth Hormone & IGF Research,2007年,17(1),pp. 47-53
Attorney, Agent or Firm:
Patent business corporation Kita Aoyama International